Operating Segments (Tables)

12 Months Ended

Dec. 31, 2021

Operating Segments

Schedule of operating segments

	For the Years Ended
	December 31,
	2021		2020
Revenues
Specialized BioTherapeutics	$	—	$	117,369
Public Health Solutions		824,268		2,242,078
Total	$	824,268	$	2,359,447
Loss from Operations
Specialized BioTherapeutics	$	(7,280,936)	$	(13,610,715)
Public Health Solutions		(647,600)		(85,417)
Corporate		(5,212,349)		(4,890,375)
Total	$	(13,140,885)	$	(18,586,507)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	7,804	$	11,839
Public Health Solutions		16,801		21,672
Corporate		9,556		28,861
Total	$	34,161	$	62,372
Other (Expense)/Income, Net
Specialized BioTherapeutics	$	135,409	$	71,974
Corporate		(410,239)		(10,882)
Total	$	(274,830)	$	61,092
Share-Based Compensation
Specialized BioTherapeutics	$	136,594	$	148,107
Public Health Solutions		21,884		47,453
Corporate		203,081		214,373
Total	$	361,559	$	409,933

	As of December 31,
	2021		2020
Identifiable Assets
Specialized BioTherapeutics	$	128,645	$	176,447
Public Health Solutions		146,296		147,784
Corporate		26,594,986		19,567,004
Total	$	26,869,927	$	19,891,235